期刊文献+

侵入性胎盘的发病原因及病理学、分子生物学特征 被引量:7

下载PDF
导出
摘要 侵入性胎盘是妊娠期危重症,常导致产后出血。胎盘绒毛滋养细胞是一种特殊的内皮细胞,其特异性侵袭和亲血管行为与侵入性胎盘的发病密切相关,当子宫内膜层损伤或发育不良时,胎盘绒毛滋养细胞侵入子宫肌层。目前,由于我国剖宫产率持续增高,创伤性内膜缺陷所致的侵入性胎盘病例明显增高。侵入性胎盘特有病理特征为合体滋养细胞表面微绒毛膜增多、缺乏子宫蜕膜层、胎盘隔减少、合体结节减少等。血管内皮生长因子、内皮因子、基质金属蛋白酶及E-钙粘连蛋白等在侵入性胎盘绒毛滋养细胞的表达,推测与侵入性胎盘发病相关。
作者 刘艳
出处 《山东医药》 CAS 北大核心 2015年第35期100-102,共3页 Shandong Medical Journal
基金 天津市卫生局科技基金项目(2012KZ025 2012KR05 2005KZ88)
  • 相关文献

参考文献23

  • 1戴钟英.侵入性胎盘的命名、发生率及病因[J].实用妇产科杂志,2008,24(12):705-707. 被引量:56
  • 2Benirschke K,Kaufmann P.Pathology of the human placenta[M].3th edi.New York,NY,Springer-Verlag,2011:192-198.
  • 3剖宫产手术的专家共识(2014)[J].中华妇产科杂志,2014,49(10):721-724. 被引量:261
  • 4Stanley J,Roobboy Malcolm C,anderson Peter Russell.女性生殖道病理学[M].回允中,译.北京:北京大学医学出版社,2005.153~161.
  • 5Ji L,Brkic J,Liu M,et al.Placental trophoblast cell differentiation:physiological regulation and pathological relevance to preeclampsia[J].Mol Aspects Med,2013,34(5):981-1023.
  • 6Cruz M,Gadea B,Garrido N,et al.Embryo quality,blastocyst and ongoing pregnancy rates in oocyte donation patients whose embryos were monitored by time-lapse imaging[J].Assist Reprod Genet,2011,28(7):569-573.
  • 7Patan S.Vasculogenesis and angiogenesis[J].Cancer Treat Res,2004,(117):3-32.
  • 8Escrich L,Grau N,Meseguer M,et al.Morphologic indicators predict the stage of chromatin condensation of human germinal vesicle oocytes recovered from stimulated cycles[J].Fertil Steril,2010,93(8):2557-2564.
  • 9Cresswell JA,Ronsmans C,Calvert C,et al.Prevalence of placenta praevia by world region:a systematic review and meta-analysis[J].Trop Med Int Health,2013,18(6):712-724.
  • 10Esakoff TF,Handler SJ,Granados JM,et al.PAMUS:placenta accreta management across the United States[J].Matern Fetal Neonatal Med,2012,25(6):761-765.

二级参考文献50

  • 1周莉,吴连方.40例植入性胎盘的回顾性分析[J].首都医科大学学报,2005,26(1):90-92. 被引量:47
  • 2王辉,张建华,吴味辛.植入性胎盘23例临床分析[J].实用妇产科杂志,2005,21(2):93-95. 被引量:65
  • 3陈莉萍,谭布珍.滋养层细胞凋亡及其调控因素与稽留流产关系的研究进展[J].江西医药,2007,42(2):173-176. 被引量:6
  • 4Bretelle F, Courbiere B, Mazouni C, et al. Management of placenta accrete: morbidity and outcome [ J]. Eurp J Obstet Gynecol, 2007,133(1) : 34- 39.
  • 5Gielchinsky Y, Rojansky N, Fasottliotis SJ, et al.Placenta accrete- summary of 10 years:a survey of 310 cases [J].Placen, 2002,28(2):210- 214.
  • 6Sumigama S, hakura A, Ota T, et al.Placenta previa increta/percreta in Japan: aretrospective study of ultrasound findings, management and clinical course [J] .J Obstet Gynecol Res ,2007,33(5) :606 - 611.
  • 7Cheung AN, Zhang HJ, Xue WC, et al. Pathogenesis of choriocar- cinoma: clinical, genetic and stem cell perspective [ J ]. Future Oncol, 2009,5 (2) :217-231.
  • 8Okumura M, Fushida K, Rezende WW, et al. Sonographic ap- pearance of gestational trophoblastic disease evolving into epitheli- oid trophoblastic tumor [ J ]. Ultrasound Obstet Gynecol, 2010,36 (2) :249-251.
  • 9Azhar M, Runyan RB, Gard C, et al. Ligand-specific function of transforming growth factor beta in epithelial-mesenchymal transition in heart development [ J ]. Dev Dyn, 2009,238 (2) :431-442.
  • 10Do TV, Kubba LA, Du H, et al. Transforming growth factor-be- tal ,transforming growth factor-beta2, and transforming growth fac- torbeta3 enhance ovarian cancer metastatic potential by inducing a Smad3-dependent epithelial-to-mesenchymal transition [ J ]. Mol Cancer Res, 2008,6(5 ) :695-705.

共引文献343

同被引文献48

  • 1殷莉,钟刚.骨桥蛋白在人子宫内膜、早孕蜕膜和绒毛中的表达及意义[J].现代妇产科进展,2007,16(9):670-672. 被引量:1
  • 2Ryan GL,Quinn TJ,Syrop CH,et al. Placenta accrete postpartum [J]. Obstet Gynecol,2002,100(5 Pt 2) : 1069-1072.
  • 3Kim S,Shin T. Immunohistochemical study of osteopontin in boartestis [J]. J Vet Sci, 2007,8 (2) : 107-110.
  • 4Gielchinsky Y,Rojansky N, Fasouliotis SJ, et al. Placenta accrete-summary of 10 years:a survey of 310 cases [J]. Placen,2002,28(2) :210-214.
  • 5Laicuori H,Kaaja R,Koistine H,et al. Leptin during and after preeclampsia or normal pregnancy:its relation to serum insulin and insulin sensitivity [J]. Metabolism,2000, 49(2) :259-263.
  • 6Ahmed M,Kundu GC. Osteopontin selectively regulates p70S6K/mTOR phosphorylation leading to NF-kappaB de- pendent AP-1-mediated 1 CAM-1 expression in breast cancer cells [J]. Mol Cancer, 2010,9 : 101.
  • 7Bandiera E,Zanotti L, Fabricio AS, et al. Cancer antigen125, human epididymis 4,kallikrein 6, osteopontin and soluble mesothelin-related peptide immunecomplexed with immunoglobulin M in epithelial ovarian cancer diag- nosis [J]. Clin Chem Lab Med,2013,51(9) : 1815-1824.
  • 8Rafal M, Sebastian S, Dariusz S, et al. Role of osteopontin in differential diagnosis of ovarian tumors [J]. Obstet Gynaecol, 2013,39(11 ) : 1518-1525.
  • 9Liang KH,Yeh CT. OPN sesame [J]. Hepatobiliary Surg Nutr, 2014,3(3) : 112-114.
  • 10Dabiri G,Heiner D,Falanga V. The emerging use of bone marrow-derived mesenchymal stem cells in the treatment of human chronic wounds [J]. Expert Opin Emerg Drugs, 2013,18(4) :405-419.

引证文献7

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部